To mask or not to mask: Modeling the potential for face mask use by the general public to curtail the COVID-19 pandemic
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Abstract Face mask use by the general public for limiting the spread of the COVID-19 pandemic is controversial, though increasingly recommended, and the potential of this intervention is not well understood. We develop a compartmental model for assessing the community-wide impact of mask use by the general, asymptomatic public, a portion of which may be asymptomatically infectious. Model simulations, using data relevant to COVID-19 dynamics in the US states of New York and Washington, suggest that broad adoption of even relatively ineffective face masks may meaningfully reduce community transmission of COVID-19 and decrease peak hospitalizations and deaths. Moreover, mask use decreases the effective transmission rate in nearly linear proportion to the product of mask effectiveness (as a fraction of potentially infectious contacts blocked) and coverage rate (as a fraction of the general population), while the impact on epidemiologic outcomes (death, hospitalizations) is highly nonlinear, indicating masks could synergize with other non-pharmaceutical measures. Notably, masks are found to be useful with respect to both preventing illness in healthy persons and preventing asymptomatic transmission. Hypothetical mask adoption scenarios, for Washington and New York state, suggest that immediate near universal (80%) adoption of moderately (50%) effective masks could prevent on the order of 17–45% of projected deaths over two months in New York, while decreasing the peak daily death rate by 34–58%, absent other changes in epidemic dynamics. Even very weak masks (20% effective) can still be useful if the underlying transmission rate is relatively low or decreasing: In Washington, where baseline transmission is much less intense, 80% adoption of such masks could reduce mortality by 24–65% (and peak deaths 15–69%), compared to 2–9% mortality reduction in New York (peak death reduction 9–18%). Our results suggest use of face masks by the general public is potentially of high value in curtailing community transmission and the burden of the pandemic. The community-wide benefits are likely to be greatest when face masks are used in conjunction with other non-pharmaceutical practices (such as social-distancing), and when adoption is nearly universal (nation-wide) and compliance is high.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263 · cited 7×
“…to the hospitalized class, HðtÞ, where they are unable to pass the disease to the general public; we suppose that some fraction of hospitalized patients ultimately require critical care (and may die) (Zhou et al., 2020), but do not explicitly disaggregate, for example, ICU and non-ICU patients.”
BackgroundInfluentialvan den Driessche, P., & Watmough, J. (2002) · Mathematical Biosciences · doi:10.1016/s0025-5564(02)00108-6 · Cited by 9,977
Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1
van Doremalen, N., Bushmaker, T., Morris, D. H., Holbrook, M. G., Gamble, A., Williamson, B. N., Tamin, A., Harcourt, J. L., Thornburg, N. J., Gerber, S. I., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2004973 · Cited by 9,951 · cited 2×
“An experimental study (van Doremalen et al., 2020) using a nebulizer found SARS-CoV-2 to remain viable in aerosols ( 5 mm) for 3 h (the study duration), but the clinical relevance of this setup is debatable (World Health Organization, 2020, p. 27).”
MethodLauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., Azman, A. S., Reich, N. G., & Lessler, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0504 · Cited by 5,970
Diekmann, O., Heesterbeek, J. A. P., & Metz, J. A. J. (1990) · Journal of Mathematical Biology · doi:10.1007/bf00178324 · Cited by 5,091
Wu, J. T., Leung, K., & Leung, G. M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30260-9 · Cited by 4,389
Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany
Rothe, C., Schunk, M., Sothmann, P., Bretzel, G., Froeschl, G., Wallrauch, C., Zimmer, T., Thiel, V., Janke, C., Guggemos, W., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001468 · Cited by 4,144
Estimates of the severity of coronavirus disease 2019: a model-based analysis
Verity, R., Okell, L. C., Dorigatti, I., Winskill, P., Whittaker, C., Imai, N., Cuomo-Dannenburg, G., Thompson, H., Walker, P. G. T., Fu, H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30243-7 · Cited by 3,660
Li, R., Pei, S., Chen, B., Song, Y., Zhang, T., Yang, W., & Shaman, J. (2020) · Science · doi:10.1126/science.abb3221 · Cited by 3,633 · cited 1×
“…healthcare workers appear to consistently protect against respiratory infection under metanalysis (MacIntyre et al., 2017; Offeddu, Yung, Low, & Tam, 2017), although clinical trials in the community have yielded more mixed results (Canini et al., 2010; Cowling et al., 2009; MacIntyre et al., 2009).”
Ferguson, N. M., Laydon, D. J., Nedjati-Gilani, G. L., Imai, N., Ainslie, K. E. C., Baguelin, M., Bhatia, S., Boonyasiri, A., Cucunubá, Z. M., Cuomo-Dannenburg, G., et al. (2020) · Spiral (Imperial College London) · doi:10.25561/77482 · Cited by 3,281
Cited by
Airborne transmission of respiratory viruses
Wang, C. C., Prather, K. A., Sznitman, J., Jimenez, J. L., Lakdawala, S. S., Tufekci, Z., & Marr, L. C. (2021) · Science · doi:10.1126/science.abd9149 · Cited by 1,543
COVID-19 and Public Transportation: Current Assessment, Prospects, and Research Needs
Tirachini, A., & Cats, O. (2020) · Journal of Public Transportation · doi:10.5038/2375-0901.22.1.1 · Cited by 781
“The effectiveness of widespread mask adoption among the population in reducing the death rate due to COVID-19 at city or country levels has also been predicted by simulation models (Eikenberry et al. 2020; Ngonghala et al. 2020).”
BackgroundNgonghala, C. N., Iboi, E., Eikenberry, S., Scotch, M., MacIntyre, C. R., Bonds, M. H., & Gumel, A. B. (2020) · Mathematical Biosciences · doi:10.1016/j.mbs.2020.108364 · Cited by 549
Self-citationFace Masks in the New COVID-19 Normal: Materials, Testing, and Perspectives
Chua, M. H., Cheng, W., Goh, S. S., Kong, J., Li, B., Lim, J. Y. C., Mao, L., Wang, S., Xue, K., Yang, L., et al. (2020) · Research · doi:10.34133/2020/7286735 · Cited by 495
Liang, M., Gao, L., Cheng, C., Zhou, Q., Uy, J. P., Heiner, K., & Sun, C. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101751 · Cited by 470
COVID-19: breaking down a global health crisis
Mallah, S. I., Ghorab, O. K., Al-Salmi, S., Abdellatif, O. S., Tharmaratnam, T., Iskandar, M. A., Sefen, J. A. N., Sidhu, P., Atallah, B., El-Lababidi, R., et al. (2021) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-021-00438-7 · Cited by 363
Wang, Z., An, C., Chen, X., Lee, K., Zhang, B., & Feng, Q. (2021) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2021.126036 · Cited by 350
Mohamadou, Y., Halidou, A., & Kapen, P. T. (2020) · Applied Intelligence · doi:10.1007/s10489-020-01770-9 · Cited by 333
Social and behavioral consequences of mask policies during the COVID-19 pandemic
Betsch, C., Korn, L., Sprengholz, P., Felgendreff, L., Eitze, S., Schmid, P., & Böhm, R. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2011674117 · Cited by 320
Stutt, R. O. J. H., Retkute, R., Bradley, M., Gilligan, C. A., & Colvin, J. (2020) · Proceedings of the Royal Society A: Mathematical, Physical and Engineering Sciences · doi:10.1098/rspa.2020.0376 · Cited by 307
Tea and tea drinking: China’s outstanding contributions to the mankind
Pan, S.-Y., Nie, Q., Tai, H.-C., Song, X.-L., Tong, Y.-F., Zhang, L.-J.-F., Wu, X.-W., Lin, Z.-H., Zhang, Y.-Y., Ye, D.-Y., et al. (2022) · Chinese Medicine · doi:10.1186/s13020-022-00571-1 · Cited by 297
Bo, Y., Guo, C., Lin, C., Zeng, Y., Li, H. B., Zhang, Y., Hossain, M. S., Chan, J. W. M., Yeung, D. W., Kwok, K. O., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.10.066 · Cited by 293
Wang, Y., Hao, H., & Platt, L. S. (2021) · Computers in Human Behavior · doi:10.1016/j.chb.2020.106568 · Cited by 257
Self-Reporting and Photothermally Enhanced Rapid Bacterial Killing on a Laser-Induced Graphene Mask
Huang, L., Xu, S., Wang, Z., Xue, K., Su, J., Song, Y., Chen, S., Zhu, C., Tang, B. Z., & Ye, R. (2020) · ACS Nano · doi:10.1021/acsnano.0c05330 · Cited by 255
O’Dowd, K., Nair, K. M., Forouzandeh, P., Mathew, S., Grant, J., Moran, R., Bartlett, J., Bird, J., & Pillai, S. C. (2020) · Materials · doi:10.3390/ma13153363 · Cited by 254
Wu, S., Dong, T., Li, Y., Sun, M., Qi, Y., Liu, J., Kuss, M. A., Chen, S., & Duan, B. (2022) · Applied Materials Today · doi:10.1016/j.apmt.2022.101473 · Cited by 250
Masks and Face Coverings for the Lay Public: A Narrative Update
Czypionka, T., Greenhalgh, T., Bassler, D., & Bryant, M. B. (2021) · Annals of Internal Medicine · doi:10.7326/m20-6625 · Cited by 82
(2022) · doi:10.1098/rsos.220600 · Cited by 12
Bacteria Filtration Efficiency for Different Types of Protective Face Masks
Linšak, Ž., Ražov, L., Furlan, N., Begić, G., Pavičić Žeželj, S., Crvelin, G., Broznić, D., & Tomić Linšak, D. (2023) · Applied Sciences · doi:10.3390/app13105972 · Cited by 5
Metadata
- Authors
- Eikenberry, S. E., Mancuso, M., Iboi, E., Phan, T., Eikenberry, K., Kuang, Y., Kostelich, E., & Gumel, A. B.
- Venue
- Infectious Disease Modelling
- Publisher
- Elsevier BV
- Published
- 2020
- Volume
- 5
- Pages
- 293-308
- ISSN
- 2468-0427 (ISSN-L)
- OpenAlex
- W3020358767
- Cited by
- 1,343
- References
- 44
- FWCI
- 46.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.